<DOC>
	<DOC>NCT01984814</DOC>
	<brief_summary>The effect of autologous bone marrow mononuclear cells on duration of survival in Amyotrophic Lateral Sclerosis patients.</brief_summary>
	<brief_title>Stem Cell Therapy for Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Survival duration in Amyotrophic Lateral Sclerosis patients who received cellular transplantation was compared to patients who did not receive cellular transplantation. Kaplan-Meier survival analysis was used for this comparison.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients with the diagnoses of definite amyotrophic lateral sclerosis. Clear information about date of onset of symptoms, documented contact information and follow up information Patients with diagnoses of Progressive Lateral sclerosis, Progressive bulbar plasy, Progressive spinal muscular atrophy, Progressive muscular atrophy, monomelicamyotrophy or madras motor neuron disease. patients with comorbidities like presence of acute infections such as Human Immunodeficiency Virus/Hepatitis B Virus/Hepatitis C Virus, malignancies, bleeding tendencies, renal failure, severe liver dysfunction and other acute medical conditions such as respiratory infection and pyrexia.</criteria>
	<gender>All</gender>
	<minimum_age>26 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>